Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis
- PMID: 23864544
- DOI: 10.1007/s00430-013-0305-2
Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis
Abstract
In this work, we propose that for further studies of the physiopathology and treatment for inflammatory bowel diseases, an integral view of the conditions, including the triad of microbiota-heat shock proteins (HSPs)-probiotics, ought to be considered. Microbiota is the complex microbial flora that resides in the gut, affecting not only gut functions but also the health status of the whole body. Alteration in the microbiota's composition has been implicated in a variety of pathological conditions (e.g., ulcerative colitis, UC), involving both gut and extra-intestinal tissues and organs. Some of these pathologies are also associated with an altered expression of HSPs (chaperones) and this is the reason why they may be considered chaperonopathies. Probiotics, which are live microorganisms able to restore the correct, healthy equilibrium of microbiota composition, can ameliorate symptoms in patients suffering from UC and modulate expression levels of HSPs. However, currently probiotic therapy follows ex-adiuvantibus criteria, i.e., treatments with beneficial effects but whose mechanism of action is unknown, which should be changed so the probiotics needed in each case are predetermined on the basis of the patient's microbiota. Consequently, efforts are necessary to develop diagnostic tools for elucidating levels and distribution of HSPs and the microbiota composition (microbiota fingerprint) of each subject and, thus, guide specific probiotic therapy, tailored to meet the needs of the patient. Microbiota fingerprinting ought to include molecular biology techniques for sequencing highly conserved DNA, e.g., genes encoding 16S RNA, for species identification and, in addition, quantification of each relevant microbe.
Similar articles
-
Use of Synbiotics for Ulcerative Colitis Treatment.Curr Clin Pharmacol. 2020;15(3):174-182. doi: 10.2174/1574884715666191226120322. Curr Clin Pharmacol. 2020. PMID: 31878863 Review.
-
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014. Microbiol Spectr. 2015. PMID: 26185088
-
Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp.Mol Nutr Food Res. 2014 May;58(5):1132-43. doi: 10.1002/mnfr.201300596. Epub 2013 Dec 18. Mol Nutr Food Res. 2014. PMID: 24347371
-
Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.World J Gastroenterol. 2014 Nov 14;20(42):15657-63. doi: 10.3748/wjg.v20.i42.15657. World J Gastroenterol. 2014. PMID: 25400449 Free PMC article. Review.
-
Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis.PLoS One. 2020 Mar 17;15(3):e0228846. doi: 10.1371/journal.pone.0228846. eCollection 2020. PLoS One. 2020. PMID: 32182248 Free PMC article.
Cited by
-
Recombinant probiotic Lactococcus lactis delivering P62 mitigates moderate colitis in mice.Front Microbiol. 2024 Apr 4;15:1309160. doi: 10.3389/fmicb.2024.1309160. eCollection 2024. Front Microbiol. 2024. PMID: 38680913 Free PMC article.
-
Remarkable impacts of probiotics supplementation in enhancing of the antioxidant status: results of an umbrella meta-analysis.Front Nutr. 2023 Aug 11;10:1117387. doi: 10.3389/fnut.2023.1117387. eCollection 2023. Front Nutr. 2023. PMID: 37637950 Free PMC article.
-
Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies.Int J Mol Sci. 2021 Oct 21;22(21):11365. doi: 10.3390/ijms222111365. Int J Mol Sci. 2021. PMID: 34768795 Free PMC article. Review.
-
Extrinsic factors influencing gut microbes, the immediate consequences and restoring eubiosis.AMB Express. 2020 Jul 25;10(1):130. doi: 10.1186/s13568-020-01066-8. AMB Express. 2020. PMID: 32710186 Free PMC article. Review.
-
Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial.Trials. 2020 Jun 23;21(1):565. doi: 10.1186/s13063-020-04523-8. Trials. 2020. PMID: 32576228 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical